| abstract |
The present invention relates to a dietary supplement for the treatment of weakness in metabolic activity containing Pantothenic acid (CoA), its precursors and/or its salts, a process for its production as well as its use. Application areas of the invention are food industry and medicine. n The invention is based of the surprising finding that the intake of pantothenic acid, pantothenic acid-CoA and/or its derivatives in a large amount has a beneficial effect on symptoms caused by weakness in metabolic activity. n The core point of the invention is that the uptake of a pantothenic acid-CoA equivalent from food is not 10 mg per day, but more than 10 3 times of this amount to provide the human organism optimally. It was also a surprising finding that the cholinergic Panthenol-CoA uptake reaction from food was taking place within a few minutes. n The dietary supplement according to the present invention is a compound for comprising 85-99% Pantothenic acid and/or its salts and other supplements if applicable. |